October 15, 2015 / 11:50 AM / 3 years ago

BUZZ-Valeant Pharmaceuticals International Inc: Subpoenaed in U.S.

** Canadian drugmaker’s U.S.-listed shares down about 10 pct at $160 premarket

** Valeant said late on Wednesday it has been subpoenaed by U.S. prosecutors seeking information on its pricing decisions, drug distribution and patient assistance programs

** Valeant, along with Turing Pharmaceuticals, has come under fire after Hillary Clinton last month underscored the prevalence of pharmaceutical “price gouging”

** CEO Pearson’s pricing strategy has been likened to that of Martin Shkreli, the controversial CEO of Turing, after the small company raised the cost of an old anti-infective drug by more than 5,000 pct

** Valeant raised prices on Isuprel by three times and on Nitropress by more than six times after buying the heart drugs in February.

** Up to Wednesday’s close, stock had fallen 18 pct since Sept. 22 when Clinton proposed a $250 monthly cap on out-of-pocket prescription drug costs.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below